Top Markets
#1 Audiera Audiera +42.05%
#2 Tutorial Tutorial +36.83%
#3 Fabric Protocol Fabric Protocol +31.97%
#4 Binance-Peg Bitcoin Cash Binance-Peg Bitcoin Cash +29.92%
#5 Bitcoin Cash Bitcoin Cash +29.09%
#6 Prom Prom +27.15%
#7 GALA GALA +27.03%
#8 Ethena Staked ENA Ethena Staked ENA +26.37%
#9 Arowana Arowana +26.33%
#10 Useless Coin Useless Coin +24.77%
Coin of the day
Audiera Audiera
Configuración
Idioma
ESPAñOL
Moneda
USD
Tema
Elicio Therapeutics, Inc. Elicio Therapeutics, Inc.

Elicio Therapeutics, Inc.

ELTX
Clasificación en acciones #24601
Elicio Therapeutics, Inc. is a clinical-stage biotechnology firm dedicated to... Elicio Therapeutics, Inc. is a clinical-stage biotechnology firm dedicated to creating a diverse array of innovative immunotherapies for the treatment of various cancers and other diseases. The company's primary experimental drug, ELI-002, is an AMP therapeutic vaccine specifically formulated to target KRAS-driven cancers. Its development portfolio also encompasses ELI-004, an AMP-modified CpG adjuvant that forms part of ELI-002; ELI-007, a lymph node-targeted AMP-peptide vaccine addressing mutant BRAF-driven cancers; and ELI-008, a multivalent lymph node-targeted AMP-peptide vaccine for cancers expressing mutant TP53. Furthermore, Elicio is advancing ELI-005, a vaccine candidate for preventing COVID-19, and ELI-011 for hematological malignancies. Another program, ELI-012, is an mKRAS TCR T cell AMP-lifier designed for combined use with mKRAS-targeted TCR T cell therapy against mKRAS-driven cancers. The company's operations are headquartered in Boston, Massachusetts.
Precio por acción
$3.09
Capitalización bursátil
$58.82M
Cambio (1 día)
0.33%
Cambio (1 año)
-73.01%
País
US
Comercio Elicio Therapeutics, Inc. (ELTX)

Categoría

Healthcare
Ganancias de Elicio Therapeutics, Inc. (ELTX)
Ganancias en 2026 TTM: 0
Secondo gli ultimi rapporti finanziari di Elicio Therapeutics, Inc., gli utili attuali della società sono 0. Nel 2026, la società ha registrato un utile di 0, igual a agli utili del 2026, che erano di 0. Gli utili mostrati in questa pagina sono quelli prima degli interessi e delle imposte, ovvero EBIT.
Historial de ganancias de Elicio Therapeutics, Inc. desde 2026 hasta 2026
Ganancias al final de cada año
Año Ganancias Cambiar
Not enough data for the provided dates.
Ganancias de empresas similares o competidoras
Empresa Ganancias Diferencia de ganancias País
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
$5.27B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
$1.95B -
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
$-3.09B -
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
$1.61B -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH